174 related articles for article (PubMed ID: 21839340)
1. Seventy-nine-year-old man with Langerhans cell histiocytosis treated with cladribine.
Black A; Bershow A; Allen PS; Crowson AN
J Am Acad Dermatol; 2011 Sep; 65(3):681-683. PubMed ID: 21839340
[No Abstract] [Full Text] [Related]
2. Cladribine is effective against cystic pulmonary Langerhans cell histiocytosis.
Lorillon G; Bergeron A; Detourmignies L; Jouneau S; Wallaert B; Frija J; Tazi A
Am J Respir Crit Care Med; 2012 Nov; 186(9):930-2. PubMed ID: 23118088
[No Abstract] [Full Text] [Related]
3. Successful treatment with cyclophosphamide of Langerhans cell histiocytosis involving the skin and lymph nodes in an adult patient.
Nakajima K; Morisawa R; Kodama H; Sano S
Clin Exp Dermatol; 2010 Oct; 35(7):791-2. PubMed ID: 20345994
[No Abstract] [Full Text] [Related]
4. [Cladribine treatment of repeatedly-relapsed Langerhans cell histiocytosis: a case report and literature review].
Yao X; Ying H; Weihong Z; Qing S; Xintian L
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):296-9. PubMed ID: 26182506
[TBL] [Abstract][Full Text] [Related]
5. Diabetes insipidus and Langerhans cell histiocytosis: a case report of reversibility with 2-chlorodeoxyadenosine.
Ottaviano F; Finlay JL
J Pediatr Hematol Oncol; 2003 Jul; 25(7):575-7. PubMed ID: 12847329
[TBL] [Abstract][Full Text] [Related]
6. Successful thalidomide treatment of adult solitary perianal Langerhans cell histiocytosis.
Li R; Lin T; Gu H; Zhou Z
Eur J Dermatol; 2010; 20(3):391-2. PubMed ID: 20146969
[No Abstract] [Full Text] [Related]
7. Langerhans cell histiocytosis: old disease new treatment.
Ng-Cheng-Hin B; O'Hanlon-Brown C; Alifrangis C; Waxman J
QJM; 2011 Feb; 104(2):89-96. PubMed ID: 21084318
[TBL] [Abstract][Full Text] [Related]
8. Complete remission of nodular pulmonary Langerhans cell histiocytosis lesions induced by 2-chlorodeoxyadenosine in a non-smoker.
Aerni MR; Aubry MC; Myers JL; Vassallo R
Respir Med; 2008 Feb; 102(2):316-9. PubMed ID: 17935961
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of cutaneous langerhans cell histiocytosis with thalidomide.
Sander CS; Kaatz M; Elsner P
Dermatology; 2004; 208(2):149-52. PubMed ID: 15057007
[TBL] [Abstract][Full Text] [Related]
10. Refractory LCH With Secondary Intracranial PNET: A Case Report and Review of Literature.
Chayapathi V; Mahajan A; Kalra M
J Pediatr Hematol Oncol; 2018 Mar; 40(2):e117-e120. PubMed ID: 28859038
[TBL] [Abstract][Full Text] [Related]
11. [Successful treatment of a case of cutaneous Langerhans cell granulomatosis with 2-chlorodeoxyadenosine and thalidomide].
Dallafior S; Pugin P; Cerny T; Betticher D; Saurat JH; Hauser C
Hautarzt; 1995 Aug; 46(8):553-60. PubMed ID: 7558825
[TBL] [Abstract][Full Text] [Related]
12. Langerhans cells histiocytosis with vulvar involvement and responding to thalidomide therapy--case report.
Fernandes LB; Guerra JG; Costa MB; Paiva IG; Duran FP; Jacó DN
An Bras Dermatol; 2011; 86(4 Suppl 1):S78-81. PubMed ID: 22068778
[TBL] [Abstract][Full Text] [Related]
13. Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study.
Donadieu J; Bernard F; van Noesel M; Barkaoui M; Bardet O; Mura R; Arico M; Piguet C; Gandemer V; Armari Alla C; Clausen N; Jeziorski E; Lambilliote A; Weitzman S; Henter JI; Van Den Bos C;
Blood; 2015 Sep; 126(12):1415-23. PubMed ID: 26194764
[TBL] [Abstract][Full Text] [Related]
14. Drug therapy for the treatment of Langerhans cell histiocytosis.
McClain KL
Expert Opin Pharmacother; 2005 Nov; 6(14):2435-41. PubMed ID: 16259575
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal involvement in disseminated Langerhans cell histiocytosis (LCH) with durable complete response to 2-chlorodeoxyadenosine and high-dose cytarabine.
Choi SW; Bangaru BS; Wu CD; Finlay JL
J Pediatr Hematol Oncol; 2003 Jun; 25(6):503-6. PubMed ID: 12794533
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy and safety of 2CdA (cladribine) in extra-pulmonary adult-onset Langerhans cell histiocytosis: analysis of 23 cases from the French Histiocytosis Group and systematic literature review.
Néel A; Artifoni M; Fontenoy AM; Tessoulin B; Lorillon G; Cohen-Aubart F; Haroche J; Genereau T; de Menthon M; Guillevin L; Maillard H; Kahn JE; Hermine O; Araujo C; Dromer C; Jullien D; Hamidou M; Donadieu J; Tazi A
Br J Haematol; 2020 Jun; 189(5):869-878. PubMed ID: 32191819
[TBL] [Abstract][Full Text] [Related]
17. Risk organ + LCH gets the one-two punch?
Stine KC
Blood; 2015 Sep; 126(12):1399-400. PubMed ID: 26384280
[TBL] [Abstract][Full Text] [Related]
18. A case of Langerhans cell histiocytosis in an adult with initial symptoms confined to the skin.
Wang X; Yang S; Tu P; Li R
Int J Dermatol; 2010 Mar; 49(3):337-9. PubMed ID: 20465678
[No Abstract] [Full Text] [Related]
19. Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis.
Grobost V; Khouatra C; Lazor R; Cordier JF; Cottin V
Orphanet J Rare Dis; 2014 Nov; 9():191. PubMed ID: 25433492
[TBL] [Abstract][Full Text] [Related]
20. Langerhans cell histiocytosis: an uncommon presentation, successfully treated by thalidomide.
Shahidi-Dadras M; Saeedi M; Shakoei S; Ayatollahi A
Indian J Dermatol Venereol Leprol; 2011; 77(5):587-90. PubMed ID: 21860158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
